MEDICINA
Departamento
University of Queensland
Brisbane, AustraliaPublicaciones en colaboración con investigadores/as de University of Queensland (9)
2022
-
IBCL-117 ASPEN: Long-Term Follow-Up Results of a Phase 3 Randomized Trial of Zanubrutinib vs Ibrutinib in Patients With Waldenström Macroglobulinemia
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S385
-
Pooled safety analysis of zanubrutinib monotherapy in patients with B-cell malignancies
Blood Advances
2021
-
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
BMC Infectious Diseases, Vol. 21, Núm. 1
-
Therapeutic anticoagulation with heparin in noncritically ill patients with covid-19
New England Journal of Medicine, Vol. 385, Núm. 9, pp. 790-802
2020
-
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: The ASPEN study
Blood, Vol. 136, Núm. 18, pp. 2038-2050
-
Bortezomib, melphalan, and dexamethasone for light-chain amyloidosis
Journal of Clinical Oncology, Vol. 38, Núm. 28, pp. 3252-3260
2018
-
Identification of a novel locus on chromosome 2q13, which predisposes to clinical vertebral fractures independently of bone density
Annals of the rheumatic diseases, Vol. 77, Núm. 3, pp. 378-385
2015
-
A global reference for human genetic variation
Nature, Vol. 526, Núm. 7571, pp. 68-74